Mariona Xercavins

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Emergence and Dissemination of Quinolone-Resistant <i>Escherichia coli</i> in the Community

Javier Garau, Mariona Xercavins, Mónica Rodríguez‐Carballeira et al. · Antimicrobial Agents and Chemotherapy · 1999 · 332 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant<i>Streptococcus pneumoniae</i>

John R. Lonks, Javier Garau, Lucía Gómez et al. · Clinical Infectious Diseases · 2002 · 327 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Relationship Between Biofilm Formation and Antimicrobial Resistance in Gram-Negative Bacteria

Virginio Cepas, Yuly López, Estela Muñoz et al. · Microbial Drug Resistance · 2018 · 319 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases

Esther Calbo, Verónica Romaní, Mariona Xercavins et al. · Journal of Antimicrobial Chemotherapy · 2006 · 303 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17